Bank Of New York Mellon Corp Concert Pharmaceuticals, Inc. Transaction History

Bank Of New York Mellon Corp

$521 Trillion
Q1 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$4.34 - $5.84 $76,071 - $102,363	17,528 New	17,528 $102,000
Q3 2022 Nov 14, 2022	SELL	$4.27 - $7.2 $93,239 - $157,219	-21,836 Reduced 15.37%	120,260 $806,000
Q2 2022 Aug 15, 2022	BUY	$2.8 - $6.36 $347,776 - $789,950	124,206 Added 694.28%	142,096 $598,000
Q1 2022 May 11, 2022	BUY	$2.73 - $3.94 $682 - $985	250 Added 1.42%	17,890 $60,000
Q2 2021 Aug 11, 2021	SELL	$3.77 - $5.24 $337,599 - $469,236	-89,549 Reduced 83.54%	17,640 $74,000

Q1 2021 May 13, 2021	BUY	$4.86 - $13.07 $37,431 - $100,665	7,702 Added 7.74%	107,189 $534,000
Q4 2020 Feb 09, 2021	SELL	$9.48 - $12.84 $27,378 - $37,081	-2,888 Reduced 2.82%	99,487 $1.26 Million
Q3 2020 Nov 12, 2020	SELL	$8.67 - $10.82 $4,525 - $5,648	-522 Reduced 0.51%	102,375 $1.01 Million
Q2 2020 Aug 12, 2020	BUY	$7.8 - $11.52 $15,904 - $23,489	2,039 Added 2.02%	102,897 $1.02 Million
Q1 2020 May 06, 2020	BUY	$5.98 - $13.09 $98,167 - $214,885	16,416 Added 19.44%	100,858 $891,000
Q4 2019 Feb 14, 2020	BUY	$5.71 - $9.22 $5,407 - $8,731	947 Added 1.13%	84,442 $778,000
Q3 2019 Nov 07, 2019	SELL	$5.88 - $12.35 $49,868 - $104,740	-8,481 Reduced 9.22%	83,495 $490,000
Q2 2019 Aug 12, 2019	SELL	$9.44 - $13.12 $135,020 - $187,655	-14,303 Reduced 13.46%	91,976 $1.1 Million
Q1 2019 May 14, 2019	BUY	$12.07 - $17.54 $25,141 - $36,535	2,083 Added 2.0%	106,279 $1.28 Million
Q4 2018 Feb 11, 2019	SELL	$11.25 - $16.17 $861,570 - $1.24 Million	-76,584 Reduced 42.36%	104,196 $1.31 Million
Q3 2018 Nov 09, 2018	BUY	$12.82 - $17.88 $127,328 - $177,584	9,932 Added 5.81%	180,780 $0
Q2 2018 Aug 06, 2018	BUY	$16.83 - $21.66 $222,223 - $285,998	13,204 Added 8.38%	170,848 $2.88 Million
Q1 2018 May 15, 2018	SELL	$19.24 - $28.03 $780,143 - $1.14 Million	-40,548 Reduced 20.46%	157,644 $3.61 Million
Q4 2017 Feb 09, 2018	BUY	$13.96 - $29.05 $2.77 Million - $5.76 Million	198,192	198,192 $5.13 Million

Others Institutions Holding CNCE

# of Institutions

Shares Held

Call Options Held

Put Options Held

Concourse Financial Group Securities, Inc. Birmingham, AL

0
Shares

$0
0.0% of portfolio

View Full List

About CONCERT PHARMACEUTICALS, INC.

Ticker CNCE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,934,600
Description
Concert Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company that develops novel small molecule drugs for the treatment of autoimmune diseases. The company's lead product candidate is CTP-543, which is in Phase III clinical trial for the treatment of alopecia areata, a serious autoimmune dermatological condition. It has s...

More about CNCE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

News

Stay updated on Bank Of New York Mellon Corp with notifications on news.

Account